Activation of NADPH oxidase is a major contributor to hypertension, reactive oxygen species generation, endothelial dysfunction and increased vascular distensibility in angiotensin II (AngII)‐induced hypertension. Since exercise has been associated with increased antioxidant enzyme expression in blood vessels, we hypothesized that exercise training would improve endothelial function and vascular distensibility in mice with AngII‐induced hypertension. C57BL/6J mice received saline or AngII (1000 ng/kg/min) via osmotic minipumps, and were assigned to sedentary or treadmill exercise groups (13 m/min for 30 minutes, 5 days/week) for 14 days. Endothelium‐dependent relaxation in response to acetylcholine and arterial distensibility were assessed in carotid arteries using a pressurized arteriograph system. Gene expression was examined by qRT‐PCR. In AngII‐treated sedentary mice, endothelium‐dependent relaxation was impaired, while distensibility was higher than in saline‐infused sedentary mice. Compared to AngII‐infused sedentary mice, however, endothelium‐dependent relaxation was partially improved, and distensibility normalized in AngII‐infused exercised mice. In response to exercise, mRNA levels of SOD1 and SOD2 in aorta were increased, while mRNA levels of NOX2 were reduced. We conclude that exercise training can dramatically improve endothelial dysfunction and reverse derangements in carotid distensibility following prolonged AngII‐induced hypertension. Additional work examining mechanisms underlying our observed transcriptional changes will be critical to development of novel therapeutic targets.
Inactivation of Endothelial Nitric Oxide Synthase Impairs Erythropoietin‐Induced Mobilization of Progenitor Cells
The present study is aimed at investigating the contribution of endothelial nitric oxide synthase (eNOS) to erythropoietin (EPO)‐induced mobilization of stem (c‐kit + ,sca‐1 + ,lin‐1 − ; KSL) cells and hematopoietic progenitor (CD34 + ) cells. Wild type (WT) and eNOS −/− mice were injected biweekly with recombinant erythropoietin (1000 U/kg, s.c.) for 14 days. The percentage of KSL cells in spleen, bone marrow and peripheral blood were quantitated by flow cytometry (Becton Dickinson) and analyzed by Cell Quest software. The effect of EPO on number of CD34 + cells in peripheral blood was quantitated by ProCount Progenitor Cell Enumeration Kit (BD Biosciences). Treatment of eNOS −/− mice with EPO increased the percentage of KSL cells by two folds only in bone marrow and spleen, while the percentage of KSL cells in peripheral blood remained unchanged. Treatment with EPO significantly increased the number of CD34 + cells in blood of WT mice (2.75 ± 0.30 cells in WT, 38.39 ± 10.35 in WT+EPO, n=5, P<0.01). However, the number of CD34 + cells remained unchanged in blood of eNOS −/− mice (2.51 ± 1.31 in eNOS −/− , 4.65 ± 1.40 in eNOS −/− + EPO, n=5, P=ns). Results of the present study suggest that eNOS plays an important role in the mobilization of hematopoietic stem/progenitor cells by erythropoietin.
Deoxyhemoglobin Kinetics During Low Intensity Exercise Step‐transitions in Aging Men and Women
Introduction Age related declines in oxidative metabolic capacity have been attributed to slowing of O 2 delivery and utilization. While these declines are pronounced in postmenopausal women, it is unclear how these changes compare with age‐matched men. This study aimed to phenotype adjustments of muscle oxy‐ and‐ deoxygenation during transitions of low intensity fixed‐load exercise in postmenopausal women and age‐matched men. Methods Healthy postmenopausal women (PW) and men (M) (N = 7 and 6; age 57 ± 7 and 61 ± 10 years; BMI 26 ± 2 and 27 ± 4 kg/m 2 , respectively, all P >0.05) completed 3 identical 8 min transients of fixed pedal rate (=35) and load (=20W) ergometry wearing bilateral thigh cuffs. After 5 min of rest, exercise began with 3 min without thigh cuff inflation followed by 5 min of exercise+cuff inflation at 90 mm Hg (to provoke locomotor congestion). Deoxy (HHb)‐ and total (Hb tot )‐ hemoglobin were measured by near‐infrared spectroscopy (NIRS) at the right calf. Data were sampled at 1 s intervals and ensemble averaged across 3 transients and binned to 10 s epochs for each participant prior to mono‐exponential modeling: Y B + A [1 − e −(t‐TD)/τ ]; where Y B = baseline value of Y for the 30 s prior to the step transition; τ = time constant; A = asymptote; TD = time delay. Mean response time (MRT) = TD + τ. Kinetics were modelled for the transition from exercise without to exercise+cuff inflation. Results Following the exercise on‐transient, TD was 9±4 vs. 7±3 s (P=0.35) and 8±4 vs. 6±3 s (P=0.28) for PW vs. M prior to the rise in ΔHHb or ΔHb tot , respectively. For PW vs. M, the A representing the rise in ΔHHb was 8±7 vs. 15±7 μM (P=0.04) and for ΔHb tot it was 13±8 vs. 18±8 μM (P=0.17), respectively. The kinetics of HHb following the exercise+cuff onset were similar for PW and M (τ=53±38 vs. 34±9 s, respectively, P=0.36) as well as for Hb tot (τ=43±29 vs. 29±16 s, respectively, P=0.43). The overall time course for the change in HHb (MRT=62±35 vs. 41±8 s, P=0.27) or Hb tot (MRT=51±27 vs. 35±14 s, P=0.31) did not differ for PW and M, respectively. Conclusions Despite age‐matched men demonstrating greater ΔHHb compared with PW, these data do not support the hypothesis that following exercise onset, the rate of locomotor hemodynamic adjustment and O 2 extraction for a given metabolic demand differ between these groups. Thus, as opposed to gross factors of blood flow and O 2 delivery, effects such as slowing of the rate of activation and/or processes regulating oxidative phosphorylation and mitochondrial respiration may play a stronger role in explaining differences in oxidative metabolic capacity between PW and M. Support or Funding Information Funding for this work was supported by National Institutes of Health [RO1‐HL126638 to TPO]; and American Heart Association [16POST30260021 to EHV] and National Institutes of Health [HL138814 to EHV]. This abstract is from the Experimental Biology 2018 Meeting. There is no full text article associated with this abstract published in The FASEB Journal .
Mechanisms of Exercise Intolerance in Heart Failure with Reduced Ejection Fraction: Influence of COPD
Introduction Exercise intolerance is a hallmark of heart failure with reduced ejection fraction (HFrEF) resulting from a variety of factors including comprised oxygen delivery. A common comorbidity of HFrEF is chronic obstructive pulmonary disease (COPD), which is independently associated with reduced exercise tolerance and cardiac output (Q) as well as peripheral dysfunction similar to HFrEF. It is currently unknown if HFrEF and coexisting COPD (HFrEF+COPD) exhibit worsened exercise tolerance and whether the mechanisms thereof are similar to HFrEF alone. We hypothesized that patients with HFrEF+COPD demonstrate further reductions in peak VO 2 and workload subsequent to a lower peak Q and arterio‐mixed venous O 2 content difference (C(a‐v)O 2 ) compared to HFrEF alone. Methods HFrEF+COPD (n=16) and HFrEF (n=17) (age: 57±7 vs 54±6 yrs; EF%: 20±5 vs 21±5; height: 173±7 vs 174±7 cm; weight: 88±14 vs 86±17 kg; all p>0.18) underwent peak exercise testing during right heart catheterization. At rest and peak exercise, invasive hemodynamic, cardiac pressures, and arterial pressures were performed. Heart rate and oxygen uptake (VO 2 ) were measured at rest and peak exercise via 12‐lead ECG and metabolic measurement system, respectively. Convective oxygen delivery was calculated as Q multiplied by CaO 2 . Results Peak exercise VO 2 and workload were lower in HFrEF+COPD compared to HFrEF (7.0±1.9 vs. 9.9±2.7 mL/min/kg; 34±7 vs. 45±12 watts; both p<0.01). At peak exercise, Q and stroke volume were lower in HFrEF+COPD than HFrEF (4.8±1.3 vs. 7.0±3.0 L/min; 52±16 vs. 75±28 mL; both p<0.01). Significant relationships existed between delta VO 2 and Q (peak exercise minus resting) in HFrEF+COPD and HFrEF (r=0.84 and r=0.89; both p<0.01); however, HFrEF+COPD had a significantly lower slope (p=0.02). Peak exercise C(a‐v)O 2 was not different between HFrEF+COPD and HFrEF (12.9±2.3 vs. 12.8±2.6 mL/dL; p=0.89). No differences were present in heart rate or hemoglobin at peak exercise (p>0.73). Delta VO 2 and C(a‐v)O 2 was significantly related for HFrEF+COPD (r=0.68; p<0.01), but not HFrEF (r=0.14, p=0.57). At peak exercise, HFrEF+COPD had lower convective oxygen delivery (845±239 vs. 1230±517 mL/min; p<0.01). Conclusions Patients with HFrEF and concurrent COPD demonstrate worsened exercise tolerance compared to HFrEF resulting from reduced oxygen delivery. These data suggest HFrEF with COPD exhibit more severe central and peripheral abnormalities than HFrEF alone. Support or Funding Information NHLBI RO1 HL126638 This abstract is from the Experimental Biology 2018 Meeting. There is no full text article associated with this abstract published in The FASEB Journal .
Poor Sleep Quality is Independently Associated with Cardiometabolic Risk Factors
Background The prevalence of inadequate sleep in the general population is rising. While the detrimental health consequences of sleep disorders such as sleep‐disordered breathing are well established, little is known on the contributory role of perceived sleep quality on cardiometabolic risk profile. Importantly, poor sleep quality may be reported even in absence of objective findings of suboptimal sleep. We hypothesized that subjective poor sleep quality would be associated with markers of cardiometabolic risk in individuals without sleep disorders. Methods We compiled data from 667 research subjects (446 males, age 36.4±13.8 years) studied in the Cardiovascular/Sleep Laboratory at Mayo Clinic from 2000 to 2017. Subjects with history of sleep disorders and/or overt cardiovascular diseases, as determined from medical record or self‐report, were excluded from this study. Health status was further confirmed by physical exam. Supine systolic and diastolic blood pressure (SBP/DBP), height, weight, and waist and hip circumferences were collected. Body mass index (BMI, kg/m 2 ) was derived from height and weight. Presence of hypertension (SBP and/or DBP ≥140/80 mmHg) and obesity (BMI ≥30 kg/m 2 ) was recorded. Subjective sleep quality was self‐reported as either good or poor. Analysis of variance and Chi‐square tests were performed to examine differences in outcome measures according to sleep quality. Logistic regression models were run to examine the predictive value of poor sleep quality for hypertension and obesity risk. Results Poor subjective sleep quality was reported by 231 individuals out of 667 (34.6%). Subjects with perceived poor sleep were older (poor sleep vs good sleep: 42.3±12.9 years vs 33.2±13.3 years, p<0.0001), with greater BMI (31.4±7 kg/m 2 vs 26.5±6.3 kg/m 2 , p<0.0001), waist (104.6±17.8 kg/m 2 vs 89.7±14.8 kg/m 2 , p<0.0001) and hip (111.8±14.8 kg/m 2 vs 102.3±11.5 kg/m 2 , p<0.0001) circumference than good sleepers. Compared to the latter group, SBP and DBP values were also higher in self‐evaluated poor sleepers (poor sleep vs good sleep, SBP: 128.8±15.5 mmHg vs 122.9±14.4 mmHg, p<0.0001; DBP: 74.5±10.6 mmHg vs 71.8±11.4 mmHg, p=0.012). Obesity was more prevalent in those with subjective poor sleep quality than in good sleepers (53.3% vs 19.7%, p<0.0001). Similarly, 72.5% of patients with hypertension reported poor sleep quality while only 27.5% of them were good sleepers (p<0.0001). In comparison to good sleep quality, perceived poor sleep was associated with 3.6 times greater risk of obesity (95% CI 2.5, 5.2, p<0.0001) and 3.5 times greater risk of hypertension (95% CI 1.7, 6.9, p=0.0004) after correcting for conventional covariates. Significance was retained after further adjustment for reported snoring and witnessed apneas. Conclusions Poor perceived sleep quality is independently associated with elevated risk of high blood pressure and excess body weight in individuals without sleep disorders. These findings favor the concept that promoting adequate sleep quality, even subjectively, may benefit cardiometabolic health. Support or Funding Information American Heart Association grant 16SDG27250156; National Institutes of Health grants RO1 HL 065176 and HL 134808. This abstract is from the Experimental Biology 2018 Meeting. There is no full text article associated with this abstract published in The FASEB Journal .
The relationship between anemia and sudden cardiac death in severe aortic stenosis
Background Aortic stenosis (AS) affects, and is associated with significant comorbidity and mortality, including sudden cardiac death (SCD) from unknown mechanisms. However, it is difficult to predict which patients with AS will suffer a SCD event. Anemia and low iron are known risk factors for mortality in heart failure populations and AS. We hypothesized that anemia in patients with AS is associated with increased risk of SCD. Purpose Understand the relationship and prognostic implications between anemia and SCD in patients with severe AS. Methods and Results We selected 8,144 of 10,850 patients with severe AS (mean transvalvular gradient ≥40 mmHg or peak velocity ≥4 m/s or calculated valve area < 1 cm 2 ) from the Mayo Clinic Aortic Stenosis Registry, which includes all consecutive patients with severe AS over the time period January 1 st , 1983 to September 30 th , 2015. Subjects in this analysis (median age 76 years and 57% male) were diagnosed starting in 1995 and had hemoglobin (Hb) measurements within one year of diagnosis and prior to intervention. The mean Hb level was 12.8 (± 1.9) g/dL. The prevalence of anemia (Hb<13.0g/dL for men, <12.0g/dL for women) was 40%, 14% microcytic, 20% macrocytic, with the remainder normocytic. Of the 8,144 patients, a total of 4,440 died (10‐year survival 39%; and 240 were confirmed as SCD events [10 year cumulative incidence 4%]). Anemia was associated with increased all‐cause mortality (HR 1.87, 95% CI 1.76–1.99, P=<0.001) and increased SCD events (HR 1.58, 95% CI 1.22–2.06, P=<0.001) in patients with severe AS. Every SD decrease in Hb (1.9 g/dL) was associated with an increased risk of SCD (HR 1.42, 95% CI 1.24–1.62, P<0.001). Conclusions Anemia is highly prevalent in patients with severe aortic stenosis and is independently associated with increased all‐cause mortality, and more specifically with increased SCD risk. Possible mechanisms include anemia aggrevating myocardial hypoxia, increasing propensity for arrhythmia and abnormal Bezold‐Jarisch reflex mismatch. Anemia may be a useful prognostic marker and a potential therapeutic target in patients with severe AS. Support or Funding Information CAAC is supported by AHA17POST33400211 and NIH HL134885. This study was supported by a grant from the Department of Cardiovascular Medicine, Mayo Clinic Rochester. This abstract is from the Experimental Biology 2018 Meeting. There is no full text article associated with this abstract published in The FASEB Journal .
Frequency of Breakfast Consumption, Obesity and Weight Gain
Background Numerous studies have identified an association between frequency of breakfast consumption and body weight in children and adolescents, indicating that those who skip this meal are more likely to gain weight and develop obesity in adulthood. However, few studies have examined the implications of infrequent breakfast consumption for obesity risk in the adult population, and available data are mixed. The purpose of this study was to investigate the role of breakfast consumption on obesity indices and weight gain in a sample of healthy adults. Methods The study sample was drawn from a cohort of consecutive subjects who were recruited for research studies at the Cardiovascular/Sleep Laboratory at Mayo Clinic from 2005 to 2017 and consisted of 347 healthy adults (215 males, mean age 35.5±15.4 years, ranging from 18 to 87 years old). Physical examination and review of medical records were conducted to ensure absence of overt disease. Measures of height, weight, waist and hip circumference were obtained. Body mass index (BMI, kg/m 2 ) and waist‐to‐hip ratio (WHR) were computed. Obesity was defined as BMI ≥30 kg/m 2 . Weight gain over the past year was quantified from self‐report. Frequency of breakfast consumption (times/week, range 0 to 7) was collected from questionnaire and coded as “never” (0 times/week), “infrequent” (1 to 4 times/week), and “frequent” (5 to 7 times/week). Only those who reported the same breakfast routine for ≥2 years were included in the analysis. Results Four percent of the sample (n=15) reported never consuming breakfast and 24% (n=85) reported eating it infrequently. Compared to the individuals who consumed it frequently, those who never or infrequently had breakfast were predominately men (P=0.049) and older (P=0.001). Waist circumference was larger in those who skipped breakfast in comparison to those who consumed it 1–4 times/week or 5–7 times/week (97.5±17.9 cm vs. 85.6±11 cm vs. 87.7±15 cm, respectively; P=0.017). There were no significant differences in hip circumference, WHR, or BMI across breakfast eating patterns. Prevalence of obesity tended to be higher among those who skipped breakfast than in those who ate it frequently (26.7% vs. 10.9%, P=0.074). Individuals who did not consume breakfast reported the greatest weight gain, followed by those who consumed it 1–4 times/week, while the lowest weight gain was reported by those who had breakfast 5–7 times/week (3.6±6.9 kg vs. 2±2.3 kg vs. 1.3±2.2 kg; P=0.002). In a multivariable model, skipping breakfast predicted weight gain independently of age, gender, and BMI (P=0.004). Conclusions Infrequent breakfast consumption is associated with indices of central obesity and weight gain, with these associations being more evident in individuals who never eat breakfast. Our findings on healthy adults are consistent with prior observations in the young, corroborating the concept that regular consumption of this meal is an important and independent contributor of healthy weight at all ages. Support or Funding Information American Heart Association grant 16SDG27250156; National Institutes of Health grants RO1 HL 114676 and HL 114024; CCaTS Early Stage Investigator Award. This abstract is from the Experimental Biology 2018 Meeting. There is no full text article associated with this abstract published in The FASEB Journal .
A Higher Foci Density of Interstitial Fibrosis and Tubular Atrophy Predicts Progressive CKD after a Radical Nephrectomy for Tumor
Significance Statement A higher percentage of the kidney cortex area that exhibits interstitial fibrosis/tubular atrophy (IF/TA) is a feature of poor prognosis on biopsy. This study describes IF/TA density (the number of IF/TA foci per area of cortex) and shows it predicts progressive CKD, independent of both percentage IF/TA and clinical characteristics among patients who have undergone nephrectomy. Other patterns of IF/TA and inflammation were not predictive for progressive CKD and mortality beyond percentage IF/TA and clinical characteristics. At the same percentage IF/TA, a higher IF/TA density suggests more scattered and widespread damage to the nephrons, with a worse kidney prognosis. This information may be helpful for accurate interpretation of the severity of “chronic changes” observed on a kidney biopsy. Background Chronic tubulointerstitial injury on kidney biopsy is usually quantified by the percentage of cortex with interstitial fibrosis/tubular atrophy (IF/TA). Whether other patterns of IF/TA or inflammation in the tubulointerstitium have prognostic importance beyond percentage IF/TA is unclear. Methods We obtained, stained, and digitally scanned full cortical thickness wedge sections of renal parenchyma from patients who underwent a radical nephrectomy for a tumor over 2000–2015, and morphometrically analyzed the tubulointerstitium of the cortex for percentage IF/TA, IF/TA density (foci per mm 2 cortex), percentage subcapsular IF/TA, striped IF/TA, percentage inflammation (both within and outside IF/TA regions), and percentage subcapsular inflammation. Patients were followed with visits every 6–12 months. Progressive CKD was defined as dialysis, kidney transplantation, or 40% decline from the postnephrectomy eGFR. Cox models assessed the risk of CKD or noncancer mortality with morphometric measures of tubulointerstitial injury after adjustment for the percentage IF/TA and clinical characteristics. Results Among 936 patients (mean age, 64 years; postnephrectomy baseline eGFR, 48 ml/min per 1.73m 2 ), 117 progressive CKD events and 183 noncancer deaths occurred over a median 6.4 years. Higher IF/TA density predicted both progressive CKD and noncancer mortality after adjustment for percentage IF/TA and predicted progressive CKD after further adjustment for clinical characteristics. Independent of percentage IF/TA, age, and sex, higher IF/TA density correlated with lower eGFR, smaller nonsclerosed glomeruli, more global glomerulosclerosis, and smaller total cortical volume. Conclusions Higher density of IF/TA foci (a more scattered pattern with more and smaller foci) predicts higher risk of progressive CKD after radical nephrectomy compared with the same percentage of IF/TA but with fewer and larger foci.
Extradural decompression versus duraplasty in Chiari malformation type I with syrinx: outcomes on scoliosis from the Park-Reeves Syringomyelia Research Consortium
OBJECTIVE Scoliosis is common in patients with Chiari malformation type I (CM-I)–associated syringomyelia. While it is known that treatment with posterior fossa decompression (PFD) may reduce the progression of scoliosis, it is unknown if decompression with duraplasty is superior to extradural decompression. METHODS A large multicenter retrospective and prospective registry of 1257 pediatric patients with CM-I (tonsils ≥ 5 mm below the foramen magnum) and syrinx (≥ 3 mm in axial width) was reviewed for patients with scoliosis who underwent PFD with or without duraplasty. RESULTS In total, 422 patients who underwent PFD had a clinical diagnosis of scoliosis. Of these patients, 346 underwent duraplasty, 51 received extradural decompression alone, and 25 were excluded because no data were available on the type of PFD. The mean clinical follow-up was 2.6 years. Overall, there was no difference in subsequent occurrence of fusion or proportion of patients with curve progression between those with and those without a duraplasty. However, after controlling for age, sex, preoperative curve magnitude, syrinx length, syrinx width, and holocord syrinx, extradural decompression was associated with curve progression > 10°, but not increased occurrence of fusion. Older age at PFD and larger preoperative curve magnitude were independently associated with subsequent occurrence of fusion. Greater syrinx reduction after PFD of either type was associated with decreased occurrence of fusion. CONCLUSIONS In patients with CM-I, syrinx, and scoliosis undergoing PFD, there was no difference in subsequent occurrence of surgical correction of scoliosis between those receiving a duraplasty and those with an extradural decompression. However, after controlling for preoperative factors including age, syrinx characteristics, and curve magnitude, patients treated with duraplasty were less likely to have curve progression than patients treated with extradural decompression. Further study is needed to evaluate the role of duraplasty in curve stabilization after PFD.
Survey Finds Gender Disparities Impact Both Women Mentors and Mentees in Gastroenterology
INTRODUCTION: Gastroenterologists at all levels of practice benefit from formal mentoring. Much of the current literature on mentoring in gastroenterology is based on expert opinion rather than data. In this study, we aimed to identify gender-related barriers to successful mentoring relationships from the mentor and mentee perspectives. METHODS: A voluntary, web-based survey was distributed to physicians at 20 academic institutions across the United States. Overall, 796 gastroenterology fellows and faculty received the survey link, with 334 physicians responding to the survey (42% response rate), of whom 299 (90%; 129 women and 170 men) completed mentorship questions and were included in analysis. RESULTS: Responses of women and men were compared. Compared with men, more women preferred a mentor of the same gender (38.6% women vs 4.2% men, P < 0.0001) but less often had one (45.5% vs 70.2%, P < 0.0001). Women also reported having more difficulty finding a mentor (44.4% vs 16.0%, P < 0.0001) and more often cited inability to identify a mentor of the same gender as a contributing factor (12.8% vs 0.9%, P = 0.0004). More women mentors felt comfortable advising women mentees about work-life balance (88.3% vs 63.8%, P = 0.0005). Nonetheless, fewer women considered themselves effective mentors (33.3% vs 52.6%, P = 0.03). More women reported feeling pressured to mentor because of their gender (39.5% vs 0.9% of men, P < 0.0001). Despite no gender differences, one-third of respondents reported negative impact of the COVID-19 pandemic on their ability to mentor and be mentored. DISCUSSION: Inequities exist in the experiences of women mentees and mentors in gastroenterology, which may affect career advancement and job satisfaction.